Chemed Corp
Last updated September 27, 2026
Organization details
- Legal name
- Chemed Corp
- Former names
- Roto-Rooter Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 8082 — Services-Home Health Care Services
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Cincinnati
- Headquarters state / province
- Ohio
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CHE
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000019584
- EIN
- 31-0791746
Board of directors
-
Andrea R. Lindell · DirectorSince 2023
-
Christopher J. Heaney · DirectorSince 2023
-
Eileen P. McCarthy · DirectorSince 2023
-
George J. Walsh III · DirectorSince 2023
-
John Meredith Mount Jr. · DirectorSince 2023
-
Kevin J. Mcnamara · Director · president and CEOSince 2023
-
Patrick P. Grace · DirectorSince 2023
-
Ron DeLyons · DirectorSince 2023
-
Thomas C. Hutton · Director · vice presidentSince 2023
-
Thomas P. Rice · DirectorSince 2023
Chief executives
Kevin J. Mcnamara
· president and CEO
Dates unknown
Director election results
Annual meeting of May 18, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
82.8%
-
88.4%
-
94.1%
-
96.3%
-
97.7%
-
98.2%
-
98.8%
-
99.4%
-
99.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $7,731,050
- 12 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 18, 2026 | Kevin J. Mcnamara Director, Officer (president and CEO) | Open-market sale | −2,000 | $501.40 | $1,002,800 |
| Aug 21, 2026 | Kevin J. Mcnamara Director, Officer (president and CEO) | Open-market sale | −2,000 | $541.16 | $1,082,320 |
| Aug 21, 2026 | LEE SPENCER S Officer (executive vice president) | Open-market sale | −1,000 | $541.04 | $541,040 |
| Aug 10, 2026 | Judkins Brian C Officer (VP and Chief Legal Officer) | Option exercise | +6,786 | $445.35 | $3,022,145 |
| Aug 10, 2026 | Judkins Brian C Officer (VP and Chief Legal Officer) | Shares withheld for tax | −5,878 | $548.96 | $3,226,787 |
| Aug 5, 2026 | Wherley Joel L Officer (CEO - Vitas Healthcare) | Option exercise | +2,599 | $445.35 | $1,157,465 |
| Aug 5, 2026 | Wherley Joel L Officer (CEO - Vitas Healthcare) | Shares withheld for tax | −2,270 | $542.62 | $1,231,747 |
| Aug 3, 2026 | Kevin J. Mcnamara Director, Officer (president and CEO) | Open-market sale | −2,000 | $539.51 | $1,079,020 |
| Jul 31, 2026 | Patrick P. Grace Director | Open-market sale | −190 | $532.00 | $101,080 |
| Jul 31, 2026 | Kevin J. Mcnamara Director, Officer (president and CEO) | Option exercise | +2,001 | $445.35 | $891,145 |
| Jul 31, 2026 | Kevin J. Mcnamara Director, Officer (president and CEO) | Shares withheld for tax | −19,802 | $529.22 | $10,479,614 |
| Jun 9, 2026 | Andrea R. Lindell Director | Open-market sale | −1,347 | $447.33 | $602,554 |
| May 29, 2026 | George J. Walsh III Director | Open-market sale | −500 | $437.83 | $218,915 |
| May 18, 2026 | George J. Walsh III Director | Grant or award | +386 | $440.77 | $170,137 |
| May 18, 2026 | John Meredith Mount Jr. Director | Grant or award | +386 | $440.77 | $170,137 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.